CSL set to invest $313m to bulk up flu, COVID-19 mRNA tech

MELBOURNE: Blood products giant CSL is investing at least $US200 million ($313 million) ... read more

Bids now due for Medical portfolio says Goldman Sachs

SYDNEY: Bids were due on Monday in the contest for Medical Property Trust’s ... read more

IFM calls in bankers for PRP Diagnostic

SYDNEY: RBC Capital Markets has front-row seats to IFM Investors’ run at PRP ... read more

Flight Centre to reopen stores as travel demand takes off again

BRISBANE: High airfares and the low Australian dollar are not dampening demand for ... read more